PTK2 and cancer: It has been indicated that TNFRSF14 may interact with FAK [37, 38], a non-receptor tyrosine protein kinase, which is well-known for its role in tumor initiation and progression and promoting the survival and immune evasion of cancer cells through kinase-dependent and kinase-independent mechanisms [37, 39–41].